Your browser is no longer supported. Please, upgrade your browser.
Settings
CARA Cara Therapeutics, Inc. daily Stock Chart
CARA [NASD]
Cara Therapeutics, Inc.
Index- P/E- EPS (ttm)-2.52 Insider Own29.45% Shs Outstand31.89M Perf Week49.35%
Market Cap842.53M Forward P/E- EPS next Y-2.25 Insider Trans5.62% Shs Float29.57M Perf Month58.11%
Income-68.80M PEG- EPS next Q-0.59 Inst Own56.40% Short Float23.89% Perf Quarter38.40%
Sales1.00M P/S842.53 EPS this Y-109.40% Inst Trans26.80% Short Ratio3.23 Perf Half Y164.99%
Book/sh1.07 P/B24.69 EPS next Y5.10% ROA-98.50% Target Price26.88 Perf Year491.05%
Cash/sh1.15 P/C22.89 EPS next 5Y- ROE-117.40% 52W Range4.60 - 28.50 Perf YTD184.39%
Dividend- P/FCF- EPS past 5Y2.40% ROI- 52W High-3.19% Beta3.21
Dividend %- Quick Ratio3.30 Sales past 5Y- Gross Margin- 52W Low499.78% ATR1.49
Employees34 Current Ratio3.30 Sales Q/Q12914.30% Oper. Margin- RSI (14)87.04 Volatility11.29% 6.79%
OptionableYes Debt/Eq0.05 EPS Q/Q-107.40% Profit Margin- Rel Volume2.28 Prev Close26.42
ShortableYes LT Debt/Eq0.05 EarningsAug 03 AMC Payout- Avg Volume2.18M Price27.59
Recom1.60 SMA2047.06% SMA5059.92% SMA200109.57% Volume4,283,914 Change4.43%
Mar-28-17Reiterated Laidlaw Buy $20 → $35
Mar-28-17Reiterated H.C. Wainwright Buy $22 → $30
Mar-10-17Reiterated Laidlaw Buy $17 → $20
Oct-13-16Initiated H.C. Wainwright Buy $20
Aug-08-16Reiterated Needham Buy $27 → $23
Feb-29-16Reiterated Laidlaw Buy $30 → $17
Nov-04-15Initiated Cantor Fitzgerald Buy
Jul-24-15Reiterated Needham Buy $22 → $27
Mar-03-15Initiated MLV & Co Buy $26
Jan-09-15Initiated Canaccord Genuity Buy $20
Dec-09-14Initiated Summer Street Research Buy $20
Feb-27-14Initiated Needham Buy $27
Feb-25-14Initiated Stifel Buy $21
Feb-25-14Initiated Canaccord Genuity Buy $25
Jun-28-17 02:25PM  Is This Small Biotech Headed For $1 Billion Market Cap Or A Pitfall? Investor's Business Daily
09:21AM  Here's Why These 2 Marijuana Stocks Skyrocketed 32% and 21% Last Week Motley Fool
08:00AM  Today's Research Reports on Trending Tickers: AVEO Pharmaceuticals and Cara Therapeutics Accesswire
Jun-27-17 04:27PM  These 3 Biotech Stocks Have Doubled This Year; Can They Keep Climbing? Motley Fool
02:43PM  Applied Optoelectronics Debuts Atop List Of Hottest Short-Selling Ideas Benzinga
08:38AM  Cara Therapeutics (CARA) Shows Strength: Stock Adds 12.2 % in Session Zacks
07:22AM  Cara Therapeutics Stock Just Hit an All-Time High: Here's Why It Could Go Even Higher Motley Fool
Jun-26-17 04:06PM  Why Cara Therapeutics Shares Are Rallying Again Today Motley Fool +12.19%
11:25AM  Cara Therapeutics Breaks Out to Fresh Highs Investopedia
08:30AM  Biotech Stocks Showing Signs of Resurgence PR Newswire
Jun-23-17 04:40PM  Pot Stock Winners of the Week Investopedia +13.93%
04:19PM  This Small Biotech Is Defying Today's Sectorwide Doldrums Investor's Business Daily
04:14PM  Biotechs Hit Pause On 5-Day Rally As Regeneron, Bluebird Topple Investor's Business Daily
12:20PM  Here's Why Cara Therapeutics Inc. Stock Is Surging Today Motley Fool
10:50AM  Cara Therapeutics Wins Big on FDA Breakthrough 24/7 Wall St.
08:42AM  Implied Volatility Surging for Cara Therapeutics (CARA) Stock Options Zacks
07:00AM  Cara Receives Breakthrough Therapy Designation from FDA for I.V. CR845 for the Treatment of Chronic Kidney Disease-Associated Pruritus in Hemodialysis Patients GlobeNewswire
Jun-22-17 09:40AM  Cara Therapeutics Stock Could Break Out on IV CR845 Data Investopedia
08:00AM  Today's Research Reports on Stocks to Watch: Hologic and Cara Therapeutics Accesswire
07:03AM  Forget Cancer Drug Stocks. Here's a Little Biotech That's Easy to Understand Motley Fool
Jun-21-17 04:36PM  Here's Why Emerging Marijuana Stock Cara Therapeutics Inc. Surged as Much as 11% Motley Fool +10.23%
02:53PM  Cara Therapeutics (CARA) Stock Rises After Cr845 Trial Update Zacks
07:00AM  Cara Therapeutics Reports Continuation of Phase 3 Trial of I.V. CR845 in Postoperative Pain Following Interim Assessment GlobeNewswire
Jun-20-17 06:47PM  Cramer's lightning round: Good news from the White House will make this stock a buy CNBC
Jun-12-17 06:47PM  Cramer's lightning round: This DuPont spin-off has moved too much CNBC
Jun-06-17 12:41PM  Harry Boxers two biotech stocks and two tech stocks to watch MarketWatch -5.05%
Jun-05-17 02:06PM  ETFs with exposure to CARA Therapeutics, Inc. : June 5, 2017 Capital Cube
May-31-17 10:36AM  3 Growth Stocks for Bright Investors Motley Fool
May-26-17 10:24AM  Better Know a Marijuana Stock: Cara Therapeutics Motley Fool
08:27AM  CARA Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : CARA-US : May 26, 2017 Capital Cube
May-23-17 01:19PM  Harry Boxer: Four stocks locked in a strong uptrend MarketWatch
May-22-17 01:26PM  ETFs with exposure to CARA Therapeutics, Inc. : May 22, 2017 Capital Cube
May-18-17 08:31AM  The Best- and Worst-Performing Marijuana Stocks Last Week Motley Fool +8.08%
May-17-17 08:00AM  Cara Therapeutics to Present at the 17th Annual Conference on Pain Therapeutics GlobeNewswire -7.20%
May-15-17 04:31PM  3 Biotech Stocks I'd Buy Right Now Motley Fool
08:19AM  CARA Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CARA-US : May 15, 2017 Capital Cube
May-12-17 04:01PM  Cara Therapeutics to Host KOL Meeting on Chronic Kidney Disease-Associated Pruritus on May 16, 2017 GlobeNewswire +7.44%
02:42PM  Why You're Smart to Buy Cara Therapeutics Stock Motley Fool
May-11-17 04:19PM  ETFs with exposure to CARA Therapeutics, Inc. : May 11, 2017 Capital Cube
May-09-17 12:05PM  CARA Therapeutics, Inc. :CARA-US: Earnings Analysis: Q1, 2017 By the Numbers : May 9, 2017 Capital Cube
May-06-17 08:22AM  Why Did Cara Therapeutics Shares Tumble 13.6% in April? Motley Fool
May-04-17 04:06PM  Cara reports 1Q loss Associated Press -6.16%
04:01PM  Cara Therapeutics Reports First Quarter 2017 Financial Results GlobeNewswire
11:00AM  Investor Network: Cara Therapeutics Inc to Host Earnings Call Accesswire
May-01-17 08:32AM  Which Marijuana Stock Will Be Next to Reach a $1 Billion Valuation? Motley Fool
Apr-27-17 08:00AM  Cara Therapeutics to Announce First Quarter 2017 Financial Results on May 4, 2017 GlobeNewswire
Apr-25-17 04:06PM  CARA Therapeutics, Inc. Value Analysis (NASDAQ:CARA) : April 25, 2017 Capital Cube
Apr-24-17 02:19PM  ETFs with exposure to CARA Therapeutics, Inc. : April 24, 2017 Capital Cube
08:40AM  CARA Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : CARA-US : April 24, 2017 Capital Cube
07:00AM  Cara Therapeutics Announces Positive Data From Quantitative Phase 1 Trial Measuring Respiratory Safety of I.V. CR845 GlobeNewswire
Apr-19-17 09:43AM  Is Cara Therapeutics About to Change How We Treat Pain? Motley Fool
Apr-18-17 07:30AM  Today's Research Reports on Biotech Stocks to Watch: Cara Therapeutics and Incyte Accesswire
07:24AM  Can Drugmakers Cure the Opioid Crisis? Motley Fool
Apr-17-17 08:20AM  Yikes! These 5 Marijuana Stocks Lost a Combined $193 Million in 2016 Motley Fool
Apr-10-17 08:25AM  5 Drug-Developing Marijuana Stocks You Need to Know Motley Fool
Apr-09-17 07:43AM  3 Marijuana Stocks to Buy if You're Leery of Buying Marijuana Stocks Motley Fool
Apr-05-17 06:59PM  Cramer Remix: Best way for you to play the turn in Europe CNBC
04:01PM  Cara Therapeutics Announces Closing of Its Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
02:08PM  5 Stocks Insiders Are Loading Up On TheStreet.com
12:21PM  Here's Why Hopeful Marijuana Stock Cara Therapeutics Surged 15% in March Motley Fool
Apr-03-17 05:29PM  CARA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:30AM  Today's Research Reports on Biotech Stocks to Watch: Bioline RX and Cara Therapeutics Accesswire
Mar-31-17 03:05PM  Cara Therapeutics Is Scratching the Itch for Promising Biotechs Motley Fool
01:39PM  Cara Therapeutics Ends Mixed Month With Upgrade From Vetr Crowd Benzinga
11:00AM  Cara Therapeutics Announces Pricing for Secondary Offering 24/7 Wall St.
Mar-30-17 09:35PM  Cara Therapeutics Announces Pricing of Its Public Offering of Common Stock GlobeNewswire -7.36%
04:42PM  3 Revolutionary Drugs for Chronic Pain Motley Fool
10:33AM  5 Top Performing Stocks of the Best ETF of Q1
09:23AM  Western Digital, Nektar Therapeutics And Two More Stocks Breaking Out
Mar-29-17 04:01PM  Cara Therapeutics Announces Proposed Offering of Common Stock GlobeNewswire +6.08%
02:10PM  Harry Boxers five technology and biotechnology stocks to watch at MarketWatch
09:10AM  Cara Therapeutics (CARA) Shows Strength: Stock Up 5.2%
09:10AM  Cara Therapeutics (CARA) Shows Strength: Stock Up 5.2% at Investopedia
08:15AM  Blog Coverage Cara Therapeutics Reported Positive Top-line Results Accesswire
Mar-28-17 05:41PM  Cara Therapeutics Delivers Important Win at Motley Fool +5.18%
04:53PM  Here's Why Cara Therapeutics Rose as Much as 11.5% Today at Motley Fool
04:30PM  Cara Therapeutics to Webcast Presentation at the 16th Annual Needham Healthcare Conference GlobeNewswire
03:02PM  Cara Therapeutics Powering to Key Resistance Levels at Investopedia
12:36PM  Caras Kidney Drug Succeeds in Mid-Stage Study at Investopedia
09:30AM  Biotech Coverage After the Collapse of Trumpcare: Today's Research Reports on Cara Therapeutics and Corbus Pharmaceuticals Accesswire
09:00AM  CARA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:25AM  Cara Therapeutics shares surge 16% on positive results in trial of UP treatment at MarketWatch
07:00AM  Cara Therapeutics Announces Positive Top-Line Data From Part A of Phase 2/3 Trial of I.V. CR845 in Chronic Kidney Disease-Associated Pruritus GlobeNewswire
Mar-27-17 03:51PM  ETFs with exposure to CARA Therapeutics, Inc. : March 27, 2017 +8.29%
Mar-24-17 12:00PM  3 Hot Biotech Stocks Now at Motley Fool
Mar-22-17 12:43PM  4 Biotech Stocks to Watch
Mar-21-17 08:09AM  4 Biotech Stocks With Jaw-Dropping Growth Potential at Motley Fool
Mar-17-17 09:33AM  5 Biotech Companies To Watch In 2017
07:30AM  5 Biotech Companies Set for Major Breakouts In 2017
07:20AM  What Makes Cara Therapeutics So Intriguing? at Motley Fool
Mar-16-17 01:04PM  CARA THERAPEUTICS, INC. Financials
Mar-14-17 02:32PM  CARA Therapeutics, Inc. :CARA-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
01:39PM  Marijuana Stocks: Sean Williams, GW Pharmaceuticals PLC- ADR (GWPH), And Cara Therapeutics Inc (CARA) at Insider Monkey
08:02AM  3 Biotech Stock Rockets With More Fuel in the Tank at Motley Fool
Mar-13-17 04:30PM  Cara Therapeutics to Present at March Medical Meetings GlobeNewswire
Mar-10-17 04:58PM  Falling Biotechs: Cara Reports Zero Sales, Ionis Downgraded -9.43%
03:26PM  Here's Why Shares of Hopeful Marijuana Stock Cara Therapeutics Inc. Went Up in Smoke at Motley Fool
02:27PM  Cara Therapeutics Reports Q4 Loss (CARA) at Investopedia
08:33AM  Are Options Traders Betting on a Big Move in Cara Therapeutics, Inc. (CARA) Stock?
07:14AM  CARA THERAPEUTICS, INC. Files SEC form 10-K, Annual Report
Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors in the United States. It is developing product candidates that target the body's peripheral nervous system. The company's lead product candidate comprises I.V. CR845, which is in Phase III clinical trials for the treatment of patients with acute postoperative pain in adult patients, as well as in Phase II/III clinical trial for the treatment of uremic pruritus disease. It is also developing Oral CR845 that is in Phase IIb clinical trial to treat moderate-to-severe acute and chronic pain, as well as in Phase I clinical trial to treat uremic pruritus; and CR701, which is in preclinical trial for the treatment of neuropathic and inflammatory pain. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing CR845 for acute pain and uremic pruritus in Japan; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing CR845 in South Korea. Cara Therapeutics, Inc. was founded in 2004 and is headquartered in Stamford, Connecticut.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RHO Ventures VI LP10% OwnerMar 31Buy18.19500,0009,095,7003,568,057Apr 03 09:19 AM